about
Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells?Is lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?Sustained proliferation in cancer: Mechanisms and novel therapeutic targetsAdipose tissue mass is modulated by SLUG (SNAI2)Designing a broad-spectrum integrative approach for cancer prevention and treatment.FUS-DDIT3 prevents the development of adipocytic precursors in liposarcoma by repressing PPARgamma and C/EBPalpha and activating eIF4E.Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice.Bcl2 is not required for the development and maintenance of leukemia stem cells in mice.Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.Cysteine-rich LIM domains of LIM-homeodomain and LIM-only proteins contain zinc but not iron.Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma.Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentationTranscriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities.Killing time for cancer stem cells (CSC): discovery and development of selective CSC inhibitors.The LIM domain: a new structural motif found in zinc-finger-like proteins.The Emerging Picture of Human Breast Cancer as a Stem Cell-based Disease.Genetic background affects susceptibility to tumoral stem cell reprogramming.Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma.Acute lymphoblastic leukemia and developmental biology: a crucial interrelationshipTumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy.Early epigenetic cancer decisions.Genetically engineered mouse models of human B-cell precursor leukemias.GEMMs addressing Pax5 loss-of-function in childhood pB-ALL.Infection Exposure Promotes ETV6-RUNX1 Precursor B-cell Leukemia via Impaired H3K4 Demethylases.Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited Susceptibility.Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma.Extremely low-frequency magnetic fields and risk of childhood leukemia: A risk assessment by the ARIMMORA consortium.Comparative dosimetry for children and rodents exposed to extremely low-frequency magnetic fields.Snail family transcription factors are implicated in thyroid carcinogenesis.Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice.Cancer development induced by graded expression of Snail in mice.SLUG in cancer development.The evolution of cancer modeling: the shadow of stem cells.Consequences of chromosomal abnormalities in tumor development.Regulation of Bcl-2 gene expression by BCR-ABL is mediated by Ras.Metabolic gatekeeper function of B-lymphoid transcription factorsLineage-specific function of Engrailed-2 in the progression of chronic myelogenous leukemia to T-cell blast crisis.Hit-and-run lymphomagenesis by the Bcl6 oncogene
P50
Q26747513-4E5590D5-CDF3-4A22-AAE7-69F6C262F831Q26779702-86587E80-6EBC-4931-ADB5-F5E34BA7E9EAQ27312570-2D239ACF-282B-48BE-A859-0DB00537BBE3Q28257913-93AACC63-8188-40F0-9BA3-A16F42E69144Q28396388-AA728649-D6BA-4240-8FC3-55C0F53855CDQ28504849-551214AF-999F-4267-A8FD-E916360BEF76Q30736359-38153F81-853C-43E4-8CA2-E5591923E269Q33348653-4971222D-0A92-4667-B957-2B77A084CA45Q33671971-690E6400-E385-4050-907A-979BE70D22A1Q33947776-0A2590C4-AE4D-4A13-ADE2-F519DD552F51Q34206916-74881019-5D85-4071-8E81-6C9A284AA87CQ34950802-725ABF97-9FBB-4522-B676-9B7EE44A0DA5Q35063947-EC3042DE-03C8-44F0-AD66-ED32B6F94387Q35189915-CCFBC362-FD16-4960-B8B2-45EDE946156AQ35669591-34F43056-B41C-4599-8238-6BDC8322DF12Q36512819-0C828E22-D3D2-4A5E-ADE4-AD30E76713C7Q36728285-65FFABFC-DBBF-4149-98CE-2F23232F8112Q37134198-E34D9C92-EFA9-42C7-AD5E-89BE9037BC5DQ37344811-D4ABD705-00FE-4AFB-ABC7-CB3BBCADEC60Q37474733-FBB0E28D-B590-48FE-9AF5-8DB473A7BB25Q37949892-79B361F7-8E5B-48BF-9899-A3033D5B88F5Q38188363-BB91E50C-77CA-45AE-8ADD-C8A05617E517Q38247928-0093424A-0F37-493D-B5D5-30ABAD8DFBDBQ38285177-F216AF7E-1677-489A-AD49-6BB629F95D81Q38655479-39079985-DBAD-4883-B3F3-45D410C3B492Q38699784-5271C4CE-46E5-4B5F-BBB0-0D30CE708310Q38832332-60C0B6D5-6A54-4873-B93F-11E273C60B98Q38837705-C7C5C74E-9822-49E2-83E3-6F68969206A5Q38893180-036BF0F8-A46A-4B94-AA71-06B1021433ABQ39768674-30CE1330-DD5E-481F-BC6B-E4E2EBABA075Q40088780-EF866159-321D-4E17-95C6-52C3A4AC4CF0Q40230301-69DAFFF5-F7ED-4D6C-84B2-36CD1B16F872Q40365089-5A46E3E0-7F3D-4F0E-B211-B6D48457373AQ40453569-69DB01E6-8F50-4BF4-8DD3-FFC331381F96Q40538740-7DF7F608-3D67-451C-A990-1479EE0A2433Q40909664-AA603938-8E7E-49CD-95F7-500BFEBFA039Q41120068-E1750C81-E033-46D7-82A2-FCD43D039DCFQ41667201-D828A23A-AABE-49E2-84A6-A9DA78E213DCQ41955151-8D847D38-0324-4A3B-8965-74CE3769EC39Q42750073-C924D661-0E39-4055-A4D4-059B698F6C87
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Isidro Sanchez-garcia
@ast
Isidro Sanchez-garcia
@en
Isidro Sanchez-garcia
@es
Isidro Sanchez-garcia
@nl
Isidro Sanchez-garcia
@sl
type
label
Isidro Sanchez-garcia
@ast
Isidro Sanchez-garcia
@en
Isidro Sanchez-garcia
@es
Isidro Sanchez-garcia
@nl
Isidro Sanchez-garcia
@sl
prefLabel
Isidro Sanchez-garcia
@ast
Isidro Sanchez-garcia
@en
Isidro Sanchez-garcia
@es
Isidro Sanchez-garcia
@nl
Isidro Sanchez-garcia
@sl
P106
P1153
7004462557
P21
P31
P496
0000-0001-6989-9905